Navigation Links
FASEB announces 2014 Science Research Conference: 2nd International Conference on Retinoids
Date:1/22/2014

Bethesda, MD This 2014 Science Research Conference focuses on how retinoids are critical for many physiological and pathological processes, and how they can be developed into drugs to combat a broad array of diseases such as cancers, and neurological, dermatological, metabolic and immune diseases. This meeting also incorporates the "2nd International Retinoid Meeting", and expands the attendance from all the international scientific communities, including those in North America, Europe and Asia.

The meeting will address questions about retinoids in biology, chemistry and diseases, and particularly will emphasize issues related to clinical application and global health/nutrition. This conference will begin with a Round Table panel, followed by talks presented by highly regarded international scientists, constituting 8 symposia on fundamental problems of Retinoids (metabolism, enzymology and signaling), cutting edge clinical relevance (cancers, immunity, neurological and metabolic diseases), and new drug development (chemical biology of Retinoids).

The conference will conclude with a Poster Award section and a Meet the Expert section to foster networking among juniors/seniors, domestic/international, and academic/clinical/industrial investigators. Attendees are from academia, clinical practice and industry, and represent a wide range of specialties including, but not limited to, biochemistry, cell biology, structural biology, genetics, physiology, nutrition, medicine, and therapeutics. This meeting is the major international meeting on Retinoids held in North America. By incorporating attendees of the International Retinoid Meeting, this conference also has the biggest international representation in the field.


'/>"/>

Contact: Robin Crawford
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB announces SRC: Molecular Mechanisms of Intestinal Lipid Transport & Metabolism
2. FASEB announces 2014 SRC: Protein Phosphorylation, Cellular Plasticity & Signaling Rewiring
3. FASEB announces 2014 SRC: Protein Interactions, Structures, Technologies & Networks
4. FASEB announces 2014 Science Research Conference: Biology & Pathobiology of Krueppel-Like Factors
5. FASEB announces BioArt image and video competition winners
6. MARC travel awards announced for the July 2013 FASEB Science Research Conferences
7. MARC travel awards announced for the June 2013 FASEB science research conferences
8. New FASEB analysis documents impact of budget cuts on biomedical research
9. FASEB MARC Travel Awards announced for the 2013 American College of Sports Medicine Northwest Chapter Meeting
10. FASEB joins President Obama in urging Congress to sustain investments in research and innovation
11. FASEB SRC announces conference registration open for: Melatonin Biology: Actions & Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2017)... March 6, 2017 Mintigo , ... today announced Predictive Sales Coach TM , its ... sales intelligence into Salesforce. This unique AI application ... sales organizations with deep knowledge of their customers ... intelligent engagement. Predictive Sales Coach extends Mintigo,s existing ...
(Date:3/2/2017)... 2, 2017 Who risk to be deprived ... the full report: https://www.reportbuyer.com/product/4313699/ WILL APPLE ... FIELD? Fingerprint sensors using capacitive technology represent a ... vendor Idex forecasts an increase of 360% of the ... of the fingerprint sensor market between 2014 and 2017 ...
(Date:2/28/2017)... --  Acuant , a leading provider of data capture ... new and core technologies building upon the acquisition of ... desktop Acuant FRM TM facial recognition and match ... manual review of identity documents by accredited professionals. ... most accurate capture software to streamline workflows by securely ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... 28, 2017 Biostage, Inc. (Nasdaq: ... bioengineered organ implants to treat cancers and other life-threatening ... that Jim McGorry, CEO of Biostage, will ... panel at the MassBio 2017 Annual Meeting ... in Cambrige, Massachussetts. The 3D Printing and BioEngineering ...
(Date:3/28/2017)... March 28, 2017 Focus ... unpredictable sector due to the scientifically intensive operations ... medical, agricultural, environmental, and industrial. In today,s pre-market research, ... Pharmaceuticals Inc. (NASDAQ: PTLA), OvaScience Inc. (NASDAQ: OVAS), ... Inc. (NASDAQ: OCUL ). Learn more ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... in the development of a new orally administered treatment for Alzheimer’s disease (AD), ... CEO John Didsbury states, “As we seek to uniquely treat the metabolic dysfunctions ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... to accelerating the fight against cancer, autoimmune disease and more through a single-cell ... single-cell metabolomics and proteomics analysis platform developed in the laboratory of Dr. ...
Breaking Biology Technology: